|
[1] FRANCHINI M, MONTAGNANA M, LIPPI G.Hepcidin and iron metabolism:from laboratory to clinical implications[J].Clinica Chimica Acta, 2010, 411 (21) :1565-1569.
|
|
[2]BHATTACHARYYA S, GHOSH J, SIL PC.Iron induces hepatocytes death via MAPK activation and mitochondria-dependent apoptotic pathway:Beneficial role of glycine[J].Free Radic Res, 2012, 46 (10) :1296-1307.
|
|
[3]PHILIPPE MA, RUDDELL RG, RAMM GA.Role of iron in hepatic fibrosis:one piece in the puzzle[J].World J Gastroenterol, 2007, 13 (35) :4746-4754.
|
|
[4]NELSON JE, WILSON L, BRUNT EM, et al.Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease[J].Hepatology, 2011, 53 (2) :448-457.
|
|
[5]FUJITA N, SUGIMOTO R, URAWA N, et al.Hepatic iron accumulation is associated with disease progression and resistance to interferon/ribavirin combination therapy in chronic hepatitis C[J].J Gastroenterol Hepatol, 2007, 22 (11) :1886-1893.
|
|
[6]COSTA-MATOS L, BATISTA P, MONTEIRO N, et al.HFE mutations and iron overload in patients with alcoholic liver disease[J].Arq Gastroenterol, 2013, 50 (1) :35-41.
|
|
[7] KO C, SIDDAIAH N, BERGER J, et al.Prevalence of hepatic iron overload and association with hepatocellular cancer in end-stage liver disease:results from the National Hemochromatosis Transplant Registry[J].Liver Int, 2007, 27 (10) :1394-1401.
|
|
[8]HAMED MA, ALI SA.Non-viral factors contributing to hepatocellular carcinoma[J].World J Hepatol, 2013, 5 (6) :311-322.
|
|
[9]ZHAO R, ZHANG LY.Recent progress in relationship between iron overload and hepatocellular carcinoma[J].J Clin Hepatol, 2011, 27 (6) :670-673. (in Chinese) 赵睿, 张岭漪.铁超载与肝细胞癌关系的研究进展[J].临床肝胆病杂志, 2011, 27 (6) :670-673.
|
|
[10] MOYER TP, HIGHSMITH WE, SMYRK TC, et al.Hereditary hemochromatosis:laboratory evaluation[J].Clin Chim Acta, 2011, 412 (17) :1485-1492.
|
|
[11] BARTON JC, BARTON JC, ACTON RT, et al.Increased risk of death from iron overload among 422 treated probands with HFE/hemochromatosis and serum levels of ferritin greater than 1000μg/L at diagnosis[J].Clin Gastroenterol Hepatol, 2012, 10 (4) :412-416.
|
|
[12] TSITSIKAS DA, NZOUAKOU R, AMEEN V, et al.Comparison of serial serum ferritin measurements and liver iron concentration assessed by MRI in adult transfused patients with sickle cell disease[J].Eur J Haematol, 2014, 92 (2) :164-167.
|
|
[13]BACON BR, ADAMS PC, KOWDLEY KV, et al.Diagnosis and management of hemochromatosis:2011 practice guideline by the American Association for the study of liver diseases[J].Hepatology, 2011, 54 (1) :328-343.
|
|
[14]FISCHER R, HARMATZ PR.Non-invasive assessment of tissue iron overload[J].ASH Education Program Book, 2009, 2009 (1) :215-221.
|
|
[15]TURLIN B, DEUGNIER Y.Evaluation and interpretation of iron in the liver[C].Semin Diagn Pathol, 1998, 15 (4) :237-245.
|
|
[16]DEUGNIER Y, TURLIN B.Pathology of hepatic iron overload[J].World J Gastroenterol, 2007, 13 (35) :4755-4760.
|
|
[17]BASSETT ML, HALLIDAY JW, POWELL LW.Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis[J].Hepatology, 1986, 6 (1) :24-29.
|
|
[18]TROTTIER BJ, BURNS LJ, DEFOR TE, et al.Association of iron-overload with allogeneic hematopoietic cell transplantation outcomes:a prospective cohort study using R2 MRI measured liver iron content[J].Blood, 2013, 122 (9) :1678-1684.
|
|
[19]SAVANI BN.Ferritin and FerriScan in HCT recipients[J].Blood, 2013, 122 (9) :1539-1541.
|
|
[20] WOOD JC.Magnetic resonance imaging measurement of iron overload[J].Curr Opin Hematol, 2007, 14 (3) :183.
|
|
[21] FRAQUELLI M, CASSINERIO E, ROGHI A, et al.Transient elastography in the assessment of liver fibrosis in adult thalassemia patients[J].Am J Hematol, 2010, 85 (8) :564-568.
|
|
[22]PAPARO F, CEVASCO L, ZEFIRO D, et al.Diagnostic value of real-time elastography in the assessment of hepatic fibrosis in patients with liver iron overload[J].Eur J Radiol, 2013, 82 (12) :e755-e761.
|
|
[23] EVERS D, KERKHOFFS JL, van EGMOND L, et al.The efficiency of therapeutic erythrocytapheresis compared to phlebotomy in relation to blood volume and delta-hematocrit:An evaluation in hereditary hemochromatosis polycythemia vera and secondary erythrocytosis[J].Transfus Apher Sci, 2013, 48 (2) :187.
|
|
[24] EVERS D, KERKHOFFS JL, van EGMOND L, et al.The efficiency of therapeutic erythrocytapheresis compared to phlebotomy:a mathematical tool for predicting response in hereditary hemochromatosis, polycythemia vera, and secondary erythrocytosis[J].J Clin Apher, 2014, 29 (3) :133-138.
|
|
[25] STEFASHYNA O, STERN M, INFANTI L, et al.Pattern of care of blood donors with early-uncomplicated hereditary haemochromatosis in a Swiss blood donation centre[J].Vox Sang, 2013, 106 (2) :111-117.
|
|
[26] FLATEN TP, AASETH J, ANDERSEN O, et al.Iron mobilization using chelation and phlebotomy[J].J Trace Elem Med Biol, 2012, 26 (2) :127-130.
|
|
[27]AYDINOK Y, ULGER Z, NART D, et al.A randomized controlled1-year study of daily deferiprone plus twice weekly desferrioxamine compared with daily deferiprone monotherapy in patients with thalassemia major[J].Haematologica, 2007, 92 (12) :1599-1606.
|
|
[28]PEPE A, MELONI A, ROSSI G, et al.Cardiac and hepatic iron and ejection fraction in thalassemia major:multicentre prospective comparison of combined deferiprone and deferoxamine therapy against deferiprone or deferoxamine monotherapy[J].J Cardiovasc Magn Reson, 2013, 15 (1) :1.
|
|
[29] PREZA GC, RUCHALA P, PINON R, et al.Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload[J].J Clin Invest, 2011, 121 (12) :4880-4888.
|
|
[30]SCHMIDT PJ, TOUDJARSKA I, SENDAMARAI AK, et al.An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe-/-mice and ameliorates anemia and iron overload in murineβ-thalassemia intermedia[J].Blood, 2013, 121 (7) :1200-1208.
|
|
[31] CORRADINI E, SCHMIDT PJ, MEYNARD D, et al.BMP6 treatment compensates for the molecular defect and ameliorates hemochromatosis in HFE knockout mice[J].Gastroenterology, 2010, 139 (5) :1721-1729.
|
|
[32]ZHEN AW, NGUYEN NH, GIBERT Y, et al.The small molecule genistein increases hepcidin expression in human hepatocytes[J].Hepatology, 2013, 58 (4) :1315-1325.
|
|
[33] O’GLASSER AY, SCOTT DL, CORLESS CL, et al.Hepatic and cardiac iron overload among patients with end-stage liver disease referred for liver transplantation[J].Clin Transplant, 2010, 24 (5) :643-651.
|
|
[34]BARDOU-JACQUET E, PHILIP J, LORHO R, et al.Liver transplantation normalizes serum hepcidin level and cures iron metabolism alterations in HFE hemochromatosis[J].Hepatology, 2013, 59 (3) :839-847.引证本文:DING R, JIA JD.Progress in evaluation and treatment of hepatic iron overload[J].J Clin Hepatol, 2014, 30 (9) :961-964. (in Chinese) 丁蕊, 贾继东.肝脏铁过载的评估及治疗新进展[J].临床肝胆病杂志, 2014, 30 (9) :961-964.
|
DownLoad: